Recall of Olympus PKS Cutting Forceps Due to Welding Defect

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Olympus Corporation of the Americas is recalling 93 units of its PKS Cutting Forceps because of potential defects in the welding process that could cause the jaw to break during clinical use.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.

Recall Article

What Happened

Olympus Corporation of the Americas has initiated a voluntary recall because the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. This defect could result in the jaw breaking during clinical use.

Which Products Are Affected

The affected product is the Olympus PKS Cutting Forceps, model number 3005PK. It includes 93 units with UDI: 00821925036000 and all unexpired lot numbers. The product is a medical device intended to be passed through a 5mm cannula for coagulation using electrosurgical energy with the PKS electrical generator, and it was distributed nationwide in the US and to countries including Canada, Mexico, EU, Australia, China, Singapore, Korea, and Japan.

What You Should Do

Consumers with the affected devices should contact Olympus Corporation of the Americas as per the initial firm notification via letter for instructions on returns or refunds. The recalling firm is located at 3500 Corporate Pkwy, Center Valley, PA 18034-8229.

Why This Matters

This recall affects 93 units of a medical device, potentially posing a risk of injury if the jaw breaks during procedures, and underscores the need for proper validation in manufacturing to ensure patient safety.

Source

This information is from the FDA recall notice, recall number Z-1642-2026. For more details, refer to the FDA website.

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Olympus Corporation of the Americas is recalling 93 units of its PKS Cutting Forceps because of potential defects in the welding process that could cause the jaw to break during clinical use.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.